Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Buy
12,129
+1,776
+17% +$208K 0.02% 97
2026
Q1
$1.25M Buy
10,353
+3,645
+54% +$421K 0.02% 91
2025
Q4
$717K Buy
6,708
+742
+12% +$69.7K 0.01% 123
2025
Q3
$501K Buy
5,966
+934
+19% +$76.9K 0.01% 118
2025
Q2
$393K Buy
5,032
+397
+9% +$31.6K 0.01% 108
2025
Q1
$384K Buy
4,635
+1,474
+47% +$138K 0.01% 95
2024
Q4
$276K Buy
3,161
+745
+31% +$76.8K 0.01% 115
2024
Q3
$246K Sell
2,416
-127
-5% -$15.1K 0.01% 123
2024
Q2
$293K Buy
+2,543
New +$328K 0.01% 109
2024
Q1
Sell
-1,694
Closed -$215K 128
2023
Q4
$215K Buy
+1,694
New +$176K 0.01% 106

Other funds holding MRK

Facet Wealth Inc's MRK Position: Q2 2026 in Review

Facet Wealth Inc increased its Merck (MRK) stake by 17% in Q2 2026, buying an estimated $208K and bringing the position to 12,129 shares worth $1.56M. The position accounts for 0.02% of the portfolio, ranked #97.

Facet Wealth Inc first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Facet Wealth Inc held 12,129 shares of Merck worth $1.56M as of Q2 2026.
  • Facet Wealth Inc bought 1,776 Merck shares in Q2 2026, an estimated $208K.
  • Merck made up 0.02% of Facet Wealth Inc's portfolio in Q2 2026, its #97 holding.
  • Facet Wealth Inc first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Facet Wealth Inc's 13F filing for Q2 2026, filed 27 Jul 2026.